Nearly 15 Percent of Plans Lack In-Network Specialists

Share this content:
Nearly 15 Percent of Plans Lack In-Network Specialists
Nearly 15 Percent of Plans Lack In-Network Specialists

WEDNESDAY, Oct. 28, 2015 (HealthDay News) -- A considerable proportion of federal marketplace plans lack at least one in-network specialist, according to a research letter published in the Oct. 27 issue of the Journal of the American Medical Association.

Stephen C. Dorner, from the Harvard T.H. Chan School of Public Health in Boston, and colleagues assessed access to outpatient specialists in federal marketplace plans using data from physician networks in 34 states offering plans through the federal marketplace during 2015 open enrollment. They searched for in-network specialists using online plan directories.

The researchers found that 13.3 and 14.1 percent of 135 plans were specialist-deficient, using a broad (100 miles) and narrow (50 miles) radius, respectively. Two plans included dermatologists and oncologists and three included endocrinologists in the broad, but not narrow, search radius. The most commonly excluded specialists were in endocrinology, rheumatology, and psychiatry; an additional seven to 14 plans had fewer than five in-network physicians in these specialists. Nine of the 34 states and 12 insurers had at least one plan that was specialist deficient. High out-of-network costs were seen for beneficiaries of specialist-deficient plans.

"In this study of federal marketplace plans, nearly 15 percent completely lacked in-network physicians for at least one specialty," the authors write. "This likely violates network adequacy requirements, raising concerns regarding patient access to specialty care."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »